Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 103 Carcinoma, Renal Cell 70 Neoplasm Metastasis 48 Neoplasms 37 Neuroendocrine Tumors 33 Kidney Neoplasms 27 Recurrence 19 Tuberous Sclerosis 18 Carcinoma, Non-Small-Cell Lung 17 Prostatic Neoplasms 16 Triple Negative Breast Neoplasms 15 Lymphoma 15 Lymphoma, Mantle-Cell 14 Lymphoma, Large B-Cell, Diffuse 14 Head and Neck Neoplasms 14 Glioblastoma 14 Colorectal Neoplasms 13 Carcinoma, Hepatocellular 13 Stomach Neoplasms 12 Lung Neoplasms 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Hodgkin Disease 12 Brain Neoplasms 12 Sarcoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Glioma 11 Waldenstrom Macroglobulinemia 10 Lymphoma, Follicular 10 Carcinoma, Neuroendocrine 10

Interventions

Ifosfamide 5 Filgrastim 5 Doxorubicin 5 Gemcitabine 4 Docetaxel 4 Radiotherapy 3 Proton Therapy 3 Carboplatin 3 regorafenib 2 ivosidenib 2 enasidenib 2 belinostat 2 Sunitinib 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Immune Checkpoint Inhibitors 2 HhAntag691 2 Fluorouracil 2 Etoposide 2 Epirubicin 2 Cyclophosphamide 2 Cisplatin 2 Chemotherapy, Adjuvant 2 Celecoxib 2 Bevacizumab 2 venetoclax 1 toripalimab 1 temsirolimus 1 tanespimycin 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chondrosarcoma × Everolimus × Clear all

NCT02008019 2017-08-07

CHONRAD

Centre Leon Berard

Phase 2 Suspended

Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡